Fei Yan
- Cancer Research top 2%
- Biomaterials top 2%
- Molecular Biology top 5%
- RNA modifications and cancer 15
- Epigenetics and DNA Methylation 15
- Redox biology and oxidative stress 10
- Cancer-related gene regulation 7
- Immunology top 5%
- Immune cells in cancer 9
- Immunotherapy and Immune Responses 7
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 21
-
- Luminescence and Fluorescent Materials 7
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Fei Yan
190 papers receiving 5.4k citations
Peers
Comparison fields: 5 of 146
- Cancer Research 838
- Biomaterials 553
- Molecular Biology 2.5k
- Immunology 732
- Biomedical Engineering 1.2k
Countries citing papers authored by Fei Yan
This map shows the geographic impact of Fei Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Yan more than expected).
Fields of papers citing papers by Fei Yan
This network shows the impact of papers produced by Fei Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Yan. The network helps show where Fei Yan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fei Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 10 | |
| 6 | 2023 | 28 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 37 | |
| 9 | 2023 | 18 | |
| 10 | 2023 | 15 | |
| 11 | 2021 | 58 | |
| 12 | 2021 | 33 | |
| 13 | 2020 | 3 | |
| 14 | 2020 | 101 | |
| 15 | 2019 | 34 | |
| 16 | 2019 | 88 | |
| 17 | 2018 | 118 | |
| 18 | 2017 | 31 | |
| 19 | 2014 | 111 | |
| 20 | 2011 | 64 |
About Fei Yan
Fei Yan is a scholar working on Toxicology, Molecular Biology, Immunology, Nephrology and Cancer Research, having authored 202 papers that have together received 5.4k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (21 papers), RNA modifications and cancer (15 papers), Epigenetics and DNA Methylation (15 papers), Redox biology and oxidative stress (10 papers), Immune cells in cancer (9 papers), Cancer-related gene regulation (7 papers), Luminescence and Fluorescent Materials (7 papers) and Immunotherapy and Immune Responses (7 papers). The work is most often cited by research in Cancer Research (838 citations), Biomaterials (553 citations), Molecular Biology (2.5k citations), Immunology (732 citations) and Biomedical Engineering (1.2k citations). Fei Yan has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Shujun Liu, Yangyang Du, Meiyu Song, Zhan Shi, Jiuxia Pang, Na Shen, Shouhua Feng, Xinguo Hou, Kunxia Cao and Aref Al‐Kali. Their work appears in journals such as Acta Biomaterialia, Chemical Engineering Journal, ACS Nano, Analytical Chemistry and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.